Beneficial Risk
The safety of approved drugs demands a different discussion for cancer patients who take drugs meant to be toxic.
By Jo Cavallo

The New Sarcoma Story
Diagnosing and treating sarcoma has become more about the patient and less about the subtype of disease.
By Beverly A. Caley

The HRT Connection
Clarifying hormone replacement therapy’s role in the recent decline in breast cancer cases.
By Elizabeth Whittington

First Line
Legislative Watch Texas may become the next state to self-fund cancer research. / People Report Lance Armstrong, Robin Roberts, and Beverly Sills. / The Place to Be Colon Cancer Alliance’s Colorectal Cancer Conference in Baltimore. / Prevention American Cancer Society launches ambitious prevention study. / House Call Why wasn’t Provenge approved? / Childhood Cancer Delayed diagnosis too common. / Destination Cancer survivor parks provide inspirational playground. / On the Web Avatars walk for cancer in Second Life’s virtual relay. / Bookshelf Tom Butler-Bowdon recounts 50 Spiritual Classics. / The Advocate [web exclusive] JoAn Niceley’s Pink Heart Funds provides hair to cancer patients.
[edited by Elizabeth Whittington]

Diagnosis Cancer
Powers of Prediction
By Amy K. Erickson

Finding Hope
Use as Directed
By Laura Beil

Moving On
All in the Family
By Charlotte Huff

Caregivers' Corner
Grief Before Death
By Marc Silver

Editor's Page

Letters from our Readers

Food for Thought
By Katy Human

Readers' Forum
By Regina L. Buchhofer

Drugs in the News
By Elizabeth Whittington

Speaking Out
By Ellen V. Sigal, PhD